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S100A4, a biomarker of epithelial mesenchymal transition (EMT), plays an important role in invasion and metastasis by promoting cancer cell motility. In oral squamous cell 
carcinoma (OSCC), metastasis results in 90% of cancer associated mortality. Objective: 
To investigate the role of S100A4 expression as an important component of the epithelial 
mesenchymal transition (EMT) program in oral squamous cell carcinoma (OSCC). 
Material and Methods: S100A4 protein expression was assessed semi-quantitatively 
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carcinoma (OSCC) and 10 normal oral mucosal biopsies. The association between the 
S100A4 overexpression and the aggressive features of OSCC were analyzed by X2 test. 
Results: Moderate to strong cytoplasmic expression of S100A4 was observed in 30 out 
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with the clinical stage, lymph node involvement, metastases, pattern of invasion and 
recurrence (p<0.05). Conclusion: S100A4 expression represents an important biomarker 
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invasion and metastasis. 
Keywords: Biomarker. Epithelial-mesenchymal transition. Oral cancer. Metastasis. 
Prognosis.
INTRODUCTION
Initiation and early growth of primary epithelial 
cancers, and acquisition of invasiveness is thought 
to herald the advanced stages of this multi-
step process that eventually leads to metastatic 
dissemination, with life-threatening consequences11. 
The genetic control and biochemical mechanisms 
underlying the acquisition of the invasive phenotype 
are mediated by the activation of an epithelial 
mesenchymal transition (EMT) program13. EMT 
is a biologic process that allows an epithelial cell 
to acquire the properties of a mesenchymal cell, 
thereby promoting invasion into the surrounding 
stroma and intravasation of tumor cells27. A number 
of distinct molecular markers are engaged in order 
to initiate EMT and enable its completion. One 
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calcium-binding protein, which is associated with the 
cells of mesenchymal origin, and deemed to play a 
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S100A4 expression levels strongly correlate 
with motility, which is a central element of the 
metastatic cascade25. In oral squamous cell 
carcinoma (OSCC), metastasis results in 90% of 
cancer associated mortality. In this work, we studied 
the role of S100A4 in oral cancer as a biomarker of 
metastasis by assessing its expression in primary 
tumors from all the clinical stages of oral cancer and 
determined the association of S100A4 expression 
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with aggressive clinico-pathological parameters 
including the pattern of invasion, distant metastasis 
and recurrence. Assessment of S100A4 in oral 
cancer may be related to the phenotypic alteration 
and thereby predict its metastatic potential.
MATERIAL AND METHODS
Patient details
The material for present study included a total 
of 57 formalin fixed paraffin embedded tissue 
sections retrieved from the departmental archives. 
Out of these, 47 were patients with carcinoma of 
the bucco-alveolar mucosal complex and of the 
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mucosal tissues, which were obtained at the time of 
extraction of impacted teeth. Only surgically treated 
cases of oral squamous cell carcinoma (OSCC) with a 
minimum follow-up period of 5 years were included 
in the study. Institutional Ethics Committee approval 
(IEC 36/2012) was obtained from Kasturba Hospital, 
Manipal, prior to carrying out the study. The patient 
demographics and other details of the cases included 
in the study are presented in Table 1. A chart 
analysis was carried out to study the expression of 
S100A4 in all these cases by immunohistochemistry 
(IHC). Tissue sections obtained from the lymph node 
constituted the positive control.
Immunohistochemistry
Immunohistochemical staining was carried out 
using indirect streptavidin biotin immunoperoxidase 
technique. The antibodies and reagents were 
obtained from Sigma – Aldrich Co. (St. Louis, MO, 
USA). Sections of 4 μm thickness taken on amino 
propyl triethoxysilane (APES) coated slides were 
incubated overnight at 48°C in a slide warmer to 
ensure complete adhesion of sections. Following 
tissue sections deparaffinization and hydration 
through descending grades of alcohol, sections 
were placed in phosphate buffered saline (PBS) 
for 30 minutes. The slides were immersed in a 
microwave resistant plastic staining jar containing 
antigen retrieval solution (10 mM sodium citrate 
buffer, pH 6.0) and maintained at 700 W power for 
10 minutes. Subsequently, the solution was allowed 
to cool at room temperature for at least 20 minutes. 
The slides were incubated in 3% hydrogen peroxide 
for 5 minutes at room temperature, following 
which slides were washed with PBS. To decrease 
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of antibodies, the slides were incubated with 5% 
bovine serum albumin (BSA) for 10 minutes at room 
temperature and washed with PBS for 5 minutes. 
The researchers applied 100 μL of the primary 
antibody (Rabbit polyclonal anti-S100A4 antibody, 
1:250) over the section completely, which was 
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chamber. The slides were rinsed with PBS and 
placed in the PBS bath for 5 minutes. After draining 
and wiping of the slides, sections were incubated 
in 100 μl of biotinylated secondary antibody, Anti-
Rabbit IgG (whole molecule - Peroxidase antibody 
produced in goat) for 30 minutes at 37°C. The 
slides were washed with PBS and placed in PBS 
bath for 5 minutes. For visualization, sections were 
incubated with freshly prepared substrate solution 
(SIGMAFAST™J6JV8Y	Z!	
5-10 minutes. This was followed by washing the 
slides in running tap water and counter staining 
with Mayer’s haematoxylin (MHS1- Haematoxylin 
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2.4) for 5 minutes, after which the slides were 
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Particulars Subset Number (%) Total
Gender Male 37 78.72 47
Female 10 21.28
Site Buccal mucosa 21 44.68 47
Alveolus 18 38.30
Floor of the mouth 8 17.02
Presentation Ulceroproliferative 26 55.32 47
Ulcer 8 17.02
Exophytic 8 17.02
Swelling 5 10.64
Habit SLT 26 55.32 47
ST 12 25.53
SLT + ST 3 6.38
NT 6 12.77
SLT – Smokeless tobacco. S – Smoking tobacco. NT- No tobacco
Table 1- The demographic variable of the cases included in the study
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the sections were dehydrated through ascending 
grades of alcohol (70%, 95% and 100%) for 2 
minutes each, cleared in xylene for 1 minute, 
mounted in a resinous media and coverslipped.
Staining interpretation
The neoplastic cell with cytoplasmic staining 
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microscope. The distribution of immunolabelling in 
neoplastic epithelial cells was determined from a 
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at the invasive front. A positive cell demonstrated a 
diffuse brown signal in the cytoplasm, independent 
of its intensity. To eliminate any inter-observer 
bias, the scoring was carried out independently by 
two observers. The degree of staining for S100A4 
was evaluated using a semi-quantitative scale29. 
Tissues were graded as absent (-) when there was 
Parameters 0 2+ 3+ Total Chi-square p value
Stage
Stage I 5 1 0 6
Stage II 1 1 0 2
Stage III 4 5 8 17 14.5 0.007
Stage IV 7 1 14 22
Total 17 8 22 47
Lymphnode 
No 8 0 2 10
Yes 3 6 20 29 22.7 ?$"$$#
Total 11 6 22 39
Tumor Size
T1 5 2 4 11
T2 2 5 7 14
T3 3 0 1 4 8.7 0.15
T4 7 1 10 18
Total 17 8 22 47
Metastasis
No 7 0 4 11
Yes 0 1 10 11 10.71 0.004
Total 7 1 14 22
Recurrence
No 11 6 11 28
Yes 0 0 11 11 11.4 0.002
Total 11 6 22 39
Grade
WDSCC 6 4 5 15
MDSCC 8 4 9 21 5.07 0.27
PDSCC 3 0 8 11
Total 17 8 22 47
Pattern of 
invasion
Type 1 2 1 1 4
Type 2 6 2 0 8
Type 3 6 3 2 11 27.4 ?$"$$#
Type 4C 3 2 7 12
Type 4D 0 0 12 12
Total 17 8 22 47
WDSCC – Well differentiated squamous cell carcinoma; MDSCC - Moderately differentiated squamous cell carcinoma; 
PDSCC - Poorly differentiated squamous cell carcinoma
Table 2- Association of S100A4 expression with clinical stage, lymph node involvement, tumor size, metastasis, recurrence, 
grade of tumor and pattern of invasion
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no staining, low (1+) when less than 25% of the 
tumor cells were positive, moderate (2+) when 25 
to 75% of the tumor cells stained positively and 
diffuse (3+) when more than 75% of the tumor cells 
were positive for S100A4. S100A4 expression was 
then correlated with clinicopathological parameters 
including primary tumor site, stage of tumor, degree 
of differentiation, lymph node metastasis and mode 
(pattern) of invasion28.
Statistics
Statistical analysis was carried out using SPSS 
version 16.0 for Windows. Kendall’s tau-b statistics 
was applied to assess the measure of agreement 
between two observers. Chi-square test was used to 
study the association between the S100A4 staining 
and clinicopathological parameters. Results were 
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RESULTS
Positive S100A4 expression in the cytoplasm of 
the tumor cells was observed in 30 out of 47 cases 
(63.82%) of OSCC. Kendall’s tau-b test between 
the two observers showed a very high level of 
agreement for the expression of S100A4 (0.8, 
p<0.001). In the control group, none of oral mucosal 
tissues were positive for S100A4 in the cytoplasm 
of the epithelium.
Out of 47 cases studied, 1/6 of stage I, 1/2 of 
stage II, 13/17 of stage III and 15/22 of stage IV 
cases showed positive S100A4 expression (Table 2). 
A strong association was noted between the stage 
of the tumor and the expression score of S100A4 
(p=0.007). S100A4 expression was positive in 12/14 
(85.7%) node positive stage III cases, of which 
7/12 were (3+) and 5/12 were (2+) for S100A4 
expression. Among the node negative cases, 1/3 
cases showed (3+) for S100A4 expression. Likewise, 
S100A4 expression was positive in 14/15 (93.3%) 
stage IV cases, of which 13/14 were (3+) and 1/14 
was (2+). Among the 7 node negative cases, 1/7 
was (3+) and the remaining 6/7 cases were negative 
for S100A4 expression. Although the cytoplasmic 
expression of S100A4 was strongly associated with 
lymph node involvement (p<0.001), there was no 
association between S100A4 expression in lymph 
node positive cases and primary size of the tumor 
(p=0.15).
With regard to distant metastasis (M), 11/22 
(50%) cases in stage IV were positive for S100A4 
expression, out of which 10/11 were (3+) and 
1/11 was (2+) for S100A4 expression. A strong 
association could be established between the 
S100A4 expression in tumor cells and distant 
metastasis (p=0.004). Likewise, 11/47 (23.4%) 
cases that recurred after treatment were either in 
stage III (2/11) or stage IV (9/11). All these cases 
showed (3+) expression for S100A4. Among the 
stage III cases that recurred, one was node positive 
and the other was negative, whereas all the 9 stage 
IV cases that recurred were node positive. There was 
a strong positive association between the S100A4 
expression and rate of recurrence (p=0.002).
With regard to the pattern of invasion among 
the positive cases, 1/6 cases of stage I showed a 
type 1 (Figure 1) pattern and 1/2 cases in stage 
II showed type 2 (Figure 2) pattern. Out of the 
13 stage III cases that showed positive S100A4 
expression, 2 were type 1, 2 others were type 2, 
3 were type 3 (Figure 3), 3 were type 4C (Figure 
4) and 3 were type 4D (Figure 5). In the same 
manner, out of the 15 stage IV cases that showed 
positive S100A4 expression, 2 were type 3, 4 were 
type 4C and 9 were type 4D. There was a strong 
association (p<0.001) between S100A4 expression 
and pattern of invasion of OSCC. However, there was 
no association seen between the S100A4 expression 
and histological grade of the OSCC (p=0.27).
Figure 1-	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Figure 2- Oral squamous cell carcinoma (OSCC) showing type 2 cord like pattern of invasion (S100 A4, 20x)
Figure 3- Oral squamous cell carcinoma (OSCC) showing type 3 pattern of invasion with groups of cells with no distinct 
borderline (S100A4, 20x)
Figure 4- Oral squamous cell carcinoma (OSCC) showing type 4C diffuse cord like pattern of invasion (S100A4, 20x)
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DISCUSSION
Oral cancer is one of the major cancers 
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decades12. Metastasis, which is responsible for 90% 
of the cancer associated mortality, is one of the 
poorly understood factors in cancer progression. 
An important step for the invasion and metastasis 
is the epithelial mesenchymal transition (EMT), 
a complex process induced by modifications 
of multiple pathways leading to a spectrum of 
epithelial cellular changes, including loss of polarity 
and cohesion, increased motility, and the acquisition 
of mesenchymal phenotype. EMT is critical for the 
invasion, progression, and metastasis in epithelial 
carcinogenesis8. Understanding the modulators of 
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targets.
Metastasis promoting S100A4 is a typical 
representative of S100 family of Ca2+-binding 
multifunctional proteins with dual extra- and 
intracellular function5. The increased expression of 
the S100A4 in invasive front of the tumor suggests 
the pivotal role played by S100A4 in invasion 
of tumor cells into the surrounding matrix. The 
acquisition of invasive phenotype with altered 
pattern of adhesion is a result of E-cadherin down 
regulation by S100A4, which the tumor cells 
acquire14" &''* 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their protein kinase C-mediated phosphorylation 
sites17" 
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by S100A4 loosens cell adhesion and allows cell 
invasion. Cell invasion is also facilitated by matrix 
metalloproteinases (MMPs), as S100A4 causes 
metastasis not only by affecting the motility of 
cells but also by affecting its invasive properties 
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their endogenous inhibitors2. A positive correlation 
of the S100A4 and MMP2 expression in oesophageal 
squamous cell carcinoma has been reported29.
S100A4 is located at the leading edge of 
migrating cells15, where it induces the formation of 
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a chemoattractant, S100A4 enhances directed 
migration. Directed migration is dependent on 
the interaction of S100A4 with myosin II-A. Thus, 
the S100A4-myosin II-A interaction does not 
only increase cell motility, but also enhances cell 
polarization and directed migration19. S100A4 
also binds to the septins 2, 6 and 7, which 
play a central role in cytokinesis, cell polarity 
determination, cytoskeletal reorganization, and 
membrane dynamics10,16. Therefore, the S100A4-
septin interaction also contributes to the process 
of migration.
S100A4 protein contr ibutes to tumor 
angiogenesis by stimulating the motility of 
endothelial cells. S100A4 binds to annexin II on 
the endothelial surface, a complex that activates 
the tissue plasminogen activator, which in turn 
converts the plasminogen to plasmin, activating 
proMMPs. Active MMPs and plasmin together 
induce extracellular matrix remodelling and 
thereby facilitate angiogenesis26. Intracellular 
S100A4 also enhances angiogenesis by interacting 
with methionine aminopeptidase 2 (MetAP2)6. 
Ca2+-dependent binding of S100A4 to MetAP2 
modulates the MetAP2 activity, which could promote 
endothelial growth and angiogenesis. This process 
of angiogenesis favors the metastasis of the tumor 
to the regional lymph nodes.
Elevated S100A4 expression has shown to be 
the marker of metastasis and poor prognosis in 
patients with pancreatic ductal adenocarcinoma23, 
prostate adenocarcinoma9, colorectal cancer4,18 and 
breast cancer24. A higher level of S100A4 expression 
has shown to correlate with auxillary lymph 
node metastasis and overall patient survival24. 
Figure 5- Oral squamous cell carcinoma (OSCC) showing type 4D diffuse widespread pattern of invasion (S100A4, 20x)
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Evidence suggesting the role for S100A4 in HNSCC, 
especially in OSCC, is scarce. Elevated S100A4 as a 
prognostic factor in metastatic cases of OSCC was 
demonstrated by Moriyama-Kita, et al.21 (2004). Our 
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in cases with regional lymphnode involvement and 
metastasis further emphasizes the role of S100A4 
in oral cancer patients with poor prognosis.
>



migration of the cells to a distant site and secondary 
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correlation with the elevated S100A4 expression 
and distant metastasis. This finding has been 
elucidated earlier in papillary thyroid carcinoma30 
and pancreatic cancer22, in which poor outcome 
of patients was related to increased S100A4 
expression coupled with decreased E cadherin 
expression.
The increased expression of S100A4 in our study 
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noted also in colorectal carcinoma4 and pancreatic 
cancer22. However, no association could be drawn 
between the elevated S100A4 level and the primary 
tumor size or histological grading in our analysis. 
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Kita, et al.21 (2004) in OSCC and Chen, et al.3 (2014) 
in lung cancer cells, in which S100A4 was frequently 
overexpressed, irrespective of histological subtype.
In our study a strong association between 
S100A4 expression and pattern of invasion could 
be elicited, with an increased expression noted in 
type 4C and type 4D pattern of invasion. Similar 
observations have been made in malignant 
melanomas where increased expression of S100A4 
in the nodular variant was noted, linking this 
association to the pattern of invasion1.
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for maintaining the stemness in head and neck 
cancer initiating cells. S100A4 controls the Notch 
and PTEN/PI3K/Akt signaling pathways, which 
regulate the self-renewal and tumorigenicity of 
stem cells or cancer stem cells20. S100A4 signaling 
pathways thus play a major role in the maintenance 
of cancer initiating cell population and contribute 
for the tumor recurrence.
CONCLUSION
In summary, the data from our study adds 
weight to the growing body of evidence that S100A4 
can be used to identify the subgroup of patients 
at high risk of metastasis and recurrence in OSCC 
cases, and that targeting S100A4 signaling might 
be a potential therapeutic target for increasing the 
patient survival.
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